NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/07/2019
Back to search
Official data from USPTO
BEAUFORT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BEAUFORT
ST13
US500000077600189Class
35, 40, 42, 45
Filing
77600189
Registration
3690806
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/07/2019
Trademark type
Word
Nice classes
35, 40, 42, 45
Filing date
10/24/2008
Registration date
09/29/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2019
Last transaction
03/07/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/25/2009
First use in commerce
06/25/2009
Drawing code
4
Owner type
16
Owner location
NORFOLK, VA, US
Examiner
GENOVESE,CARRIE A
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
BEAUFORT, LLC
Beaufort Advisors, LLC
Representatives
TIMOTHY J. LOCKHART WILLCOX & SAVAGE, P.C.
Technical classification
Nice Classes
Class 35Class 40Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Regulatory submission managementassisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
Class 40
Consulting services in the field of manufacturing compliance and validationproviding technical advice related to the manufacture of pharmaceuticals
Class 42
Contract research organization (CRO) servicesmonitoring of clinical trials for investigational drugs of biotech and pharmaceutical companiesclinical trial project management and quality assurancemedical writing of investigational drug protocolsmedical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trialsdrug developmentmanufacturing environmental compliance and validationadvanced technology in the pharmaceutical fieldmedical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international healththe pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsdevices and biologics
Class 45
Legal researchregulatory research in the pharmaceutical industrybiotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for othersreviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceuticalveterinarypharmacogenomicbiotechnical and medical products and devices; providing information relating to legal affairsproviding regulatory information relating to the development and validation of drugsdevices and biologics; regulatory compliance consulting as it applies to clinical trialsmonitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation servicespreparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validationregulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvementproviding independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/07/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/07/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/07/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
02/03/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/29/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/20/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/20/2016
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/25/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/25/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/24/2015
ES8R
TEAS SECTION 8 RECEIVED
09/14/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/07/2010
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
09/29/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/25/2009
ALIE
ASSIGNED TO LIE
08/25/2009
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/20/2009
IUAA
USE AMENDMENT ACCEPTED
08/20/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2009
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/04/2009
IUAF
USE AMENDMENT FILED
08/04/2009
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/03/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2009
GNRT
NON-FINAL ACTION E-MAILED
02/03/2009
CNRT
NON-FINAL ACTION WRITTEN
02/03/2009
DOCK
ASSIGNED TO EXAMINER
01/27/2009
MPMK
NOTICE OF PSEUDO MARK MAILED
10/29/2008
NWAP
NEW APPLICATION ENTERED
10/28/2008
Continuous trademark protection
Get notified about every new filing that threatens BEAUFORT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.